NFKB1 and melanoma: Moreover, to better understand the involvement of NF-κB signaling pathway in the iNOS expression inhibition mediated by the co-treatment of melatonin and vemurafenib in melanoma cells, we then investigated the upstream signaling molecules of NF-κB pathway.